400 related articles for article (PubMed ID: 19525189)
1. Hodgkin lymphoma: an update on its biology with new insights into classification.
Mani H; Jaffe ES
Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
3. How immunologic and genetic biomarkers impact Hodgkin lymphoma classification, diagnosis, and management: a huge potential that yet needs to be exploited.
Carbone A; Gloghini A
Int J Biol Markers; 2018 May; 33(2):137-140. PubMed ID: 29099538
[TBL] [Abstract][Full Text] [Related]
4. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma.
Calvo KR; Traverse-Glehen A; Pittaluga S; Jaffe ES
Adv Anat Pathol; 2004 Sep; 11(5):227-38. PubMed ID: 15322489
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
7. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
8. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
Fraga M; Forteza J
Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's lymphoma: the pathologist's viewpoint.
Pileri SA; Ascani S; Leoncini L; Sabattini E; Zinzani PL; Piccaluga PP; Pileri A; Giunti M; Falini B; Bolis GB; Stein H
J Clin Pathol; 2002 Mar; 55(3):162-76. PubMed ID: 11896065
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
12. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
13. Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.
Harris NL
Mod Pathol; 2013 Jan; 26 Suppl 1():S57-70. PubMed ID: 23281436
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.
King RL; Howard MT; Bagg A
Adv Anat Pathol; 2014 Jan; 21(1):12-25. PubMed ID: 24316907
[TBL] [Abstract][Full Text] [Related]
15. Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer; 2003 Sep; 106(5):706-12. PubMed ID: 12866030
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin lymphomas: current understanding of pathogenesis and pathomorphology].
Pajor L
Orv Hetil; 2002 Mar; 143(13):651-61. PubMed ID: 11975042
[TBL] [Abstract][Full Text] [Related]
17. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and pathologic features of Hodgkin lymphoma.
Nakatsuka S; Aozasa K
Int J Hematol; 2006 Jun; 83(5):391-7. PubMed ID: 16787868
[TBL] [Abstract][Full Text] [Related]
20. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]